Aids Glossary: A-B
Description
This article is from the Health Articles series.
Aids Glossary: A-B
Adjuvant: A substance that enhances the immune-stimulating properties of a vaccine or the effects of a drug.
Adverse event: In a clinical trial, an unwanted effect detected in participants. The term is used whether or not the effect can be attributed to the vaccine or drug under study.
Adverse reaction (side effect): In a clinical trial, an unwanted effect detected in participants and attributed to a drug or vaccine.
AIDS: The late stage of HIV disease, characterized by a deterioration of the immune system and a range of opportunistic infections and malignancies.
Amino acids: Substances of which proteins are made.
Antibodies (immunoglobulins): Infection-fighting proteins produced by B cells. Antibodies bind to antigens.
Antigen: Any material that elicits an immune response.
Anti-idiotype: An antibody that is the mirror image of another antibody.
Apoptosis: Cellular suicide, also known as programmed cell death. HIV may induce apoptosis in both infected and uninfected immune system cells.
Arm: A group of participants in a clinical trial, all of whom receive the same treatment, intervention or placebo.
Attenuated: Weakened or decreased. For example, an attenuated virus can no longer produce disease but might be used as a vaccine.
B cell: A white blood cell (lymphocyte) of the immune system. B cells produce proteins called antibodies.
Baculovirus: A virus of insects used in the production of some HIV vaccines.
Baseline: The first or starting measurements in a study.
Blinded study: A clinical trial in which participants are unaware as to whether or not they are in the experimental or control arm of the study. See double-blind.
Binding antibody: An antibody that attaches to some part of HIV. Binding antibodies may or may not adversely affect the virus.
Booster: A second or later dose of a vaccine given to increase the immune response to the original dose.
Breakthrough infection: An infection that occurs in a volunteer during the course of a vaccine trial.
Continue to:
My Books
